Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Should older men be treated with testosterone?].

Johan Svartberg1

  • 1Endokrinologisk seksjon, Medisinsk avdeling B, Universitetssykehuset Nord-Norge, 9038 Tromsø. johan.svartberg@unn.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis.

The lancet. Healthy longevity·2023
Same author

Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis.

The lancet. Healthy longevity·2022
Same author

Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.

BMC cardiovascular disorders·2021
Same author

GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility.

Nature communications·2021
Same author

A man in his sixties with dyspnoea and oedema.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2020
Same author

Estimated 8-year cumulative incidence of diabetes mellitus among Sami and non-Sami inhabitants of Northern Norway - The SAMINOR Study.

BMC endocrine disorders·2019

Testosterone therapy may improve bone density, body composition, and strength in older men with hypogonadism. Long-term cardiovascular and prostate effects require further study before general recommendations.

Area of Science:

  • Endocrinology
  • Geriatrics
  • Men's Health

Context:

  • Male hypogonadism presents with low testosterone and symptoms like reduced libido and muscle mass.
  • These symptoms can overlap with those experienced by some aging men.
  • The use of testosterone therapy in older men is debated despite increasing prescriptions.

Purpose:

  • To review recent literature on testosterone substitution in older men.
  • To discuss the current understanding of testosterone treatment for aging men.
  • To evaluate the benefits and risks of testosterone therapy in this demographic.

Summary:

  • Testosterone substitution in elderly men shows varied results, potentially improving bone mineral density, body composition, and physical strength.
  • Short-term complications are minimal, but long-term effects on the cardiovascular system and prostate remain uncertain.

Related Experiment Videos

  • Treatment may be considered for hypogonadal men with symptoms, requiring individualized care by specialists.

    • Impact:

    • Highlights the need for large prospective studies to establish general recommendations for testosterone therapy in aging men.
    • Emphasizes individualized treatment approaches for hypogonadal men presenting with clinical symptoms.
    • Informs clinical decision-making regarding testosterone therapy in older men, balancing potential benefits with uncertainties.